 | | (introductory text...) |
| | Abstract |
| | Acknowledgments |
| | Information on authors |
| | Exchange rates used in the report |
 | | Chapter 1: Policies for praziquantel* |
| | Chapter 2: Bayer & E. Merck: Discovery and development of praziquantel* |
| | Chapter 3: Shin Poong Pharmaceutical Co.: Process development in the Republic of Korea* |
| | Chapter 4: The Egyptian International Pharmaceutical Industries Co.: Praziquantel formulation* |
| | Chapter 5: The international supply of praziquantel* |
| | Chapter 6: Demand for praziquantel and national distribution* |
| | Chapter 7: Prices and production costs of praziquantel* |
| | Other documents in the DAP Research Series |
| | DAP Research Series No. 26 |
